loader image
Thursday, August 28, 2025
86 F
McAllen
- Advertisement -

Cancer patients urged to seek third dose of mRNA COVID-19 vaccine

Translate to Spanish or other 102 languages!

Mayo Clinic Cancer Center announced on Tuesday, Aug. 31, that it is following recommendations from the National Comprehensive Cancer Network that encourage cancer patients to receive a third dose of a messenger RNA COVID-19 vaccine. Image for illustration purposes.

Mega Doctor News

- Advertisement -

by Mayo Clinic 

Newswise — ROCHESTER, Minn. ― Mayo Clinic Cancer Center announced on Tuesday, Aug. 31, that it is following recommendations from the National Comprehensive Cancer Network that encourage cancer patients to receive a third dose of a messenger RNA COVID-19 vaccine. The Moderna and Pfizer COVID-19 vaccines are messenger RNA vaccines.

If patients were vaccinated with the Johnson & Johnson COVID-19 vaccine, no third dose is recommended at this time. The Johnson & Johnson COVID-19 vaccine is an adenovirus vaccine ― not a messenger RNA vaccine.

- Advertisement -

“The updated guidelines for cancer patients from NCCN are based on the latest data and approvals from the FDA (Food and Drug Administration) and CDC (Centers for Disease Control and Prevention) regarding administration of a third messenger RNA vaccine dose for cancer patients and immunocompromised people,” says Robert McWilliams M.D., a medical oncologist. Dr. McWilliams is chair of Mayo Clinic’s Cancer Center Practice Committee.

Here’s who should receive a third dose of a messenger RNA COVID-19 vaccine:

  • Patients with new or recurring solid tumors receiving treatment within one year of their initial vaccine dose, regardless of their type of cancer therapy.
  • Patients with active blood cancers, regardless of whether they receive cancer therapy.
  • Patients who received a stem cell transplant or engineered cellular therapy, such as chimeric antigen receptor-T cell therapy, especially within the past two years.
  • Patients who received allogeneic stem cell transplants and are on immunosuppressive therapy or transplant patients with a history of graft-versus-host disease, regardless of transplant timing.
  • Patients with an additional immunosuppressive condition, such as HIV or patients being treated with immunosuppressive agents unrelated to their cancer therapy.

Review the updated vaccination guidelines for cancer patients on the National Comprehensive Cancer Network website.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Top 10 Things to Know About the New AHA/ACC High Blood Pressure Guidelines

Mega Doctor News American Heart Association • 1. There is stronger proof...

Ivermectin Access Expands Under New State Law

Mega Doctor News Mega Doctor News Texas has enacted House Bill 25 (HB...

Hidalgo County Health Dept. to Unveil First OnMed CareStation Offering No-Cost Primary Care, Sept 3rd

Mega Doctor News The Hidalgo County Health & Human Services Department (HCHD)...

STHS Looking to Fill 200+ Positions at Aim for the Star Career Fair, Sept. 10th

Mega Doctor News It takes a strong team of clinical and non-clinical staff to deliver...
- Advertisement -
×